BOSTON SCIENTIFIC CORP

Boston Scientific insider buys: CFO Monson Jonathan’s July 1 purchase shows steady confidence, hinting at long‑term upside for the medical‑device stock.

Boston Scientific CEO’s 386,755‑share sale signals potential confidence shift; investors weigh insider move against strong product pipeline and market upside.

Boston Scientific insiders buy zero‑cash deferred stock units, signaling confidence that the firm’s long‑term growth will boost share value.

Insider buying by Boston Scientific’s Woodworth signals confidence amid regulatory wins, offering investors a cautious green light before the earnings call.

CEO’s record insider buying of Boston Scientific signals confidence, hinting at a rebound and potential upside amid strong pipeline and market positioning.